The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination-Reference-Cited by-同舟云学术

The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination

Published:2023-01 Issue: Volume:69 Page:104425
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Baker David^ORCID,Forte Eugenia,Pryce Gareth,Kang Angray S.,James Louisa K.,Giovannoni Gavin,Schmierer Klaus

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference187 articles.

1. Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial;Abhishek;Lancet Respir. Med.,2022

2. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies;Achiron;Ther. Adv. Neurol. Disord.,2021

3. Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod;Achiron;J. Neurol.,2022

4. SARS-CoV-2 mRNA vaccination in people with multiple sclerosis treated with fingolimod: protective humoral immune responses may develop after the preferred third shot;Achtnichts;Vaccines (Basel),2022

5. Different type and timing of S1P receptor modulator therapy impacts T and B cell response after SARS-CoV2 vaccination P316;Akgün;Multip. Scler. J.,2022

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma;Vaccines;2024-06-19

2. The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases;Current Topics in Medicinal Chemistry;2024-04-26

3. Synthesis, radiosynthesis and biochemical evaluation of fluorinated analogues of sphingosine-1-phosphate receptor 3 specific antagonists using PET;Bioorganic & Medicinal Chemistry;2024-04

4. Update des Addendums zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch-entzündlichen Darmerkrankungen in Bezug auf COVID-19 (Version 2.0);Zeitschrift für Gastroenterologie;2024-04

5. Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review;Annals of Clinical and Translational Neurology;2024-02-16